A 70 year old man has been taking Bendroflumethiazide for hypertension for many years. A recent routine blood test revealed a moderate neutropenia, thrombocytopenia and raised alkaline phosphatase level. Subsequent investigation has shown a monoclonal gammopathy with no evidence of myeloma or other serious pathology. Could the BFZ be implicated in these findings?
Hematologic side effects from bendroflumethiazide are rare. Rare cases of immune-complex hemolytic anemia, aplastic anemia, and thrombocytopenia have been associated with thiazide diuretics.
Read more: https://www.drugs.com/sfx/bendroflumethiazide-side-effects.html#ixzz0wFRAFA1z
Monoclonal gammopathy of undetermined significance (MGUS) is a blood disorder that occurs when there is overgrowth of identical plasma cells in bone marrow. Since it is the job of any given plasma cell to make a single (monoclonal) immunoglobulin protein, an increased population of identical bone marrow plasma cells may be detected by discovery of a monoclonal protein (M protein) in the blood stream. Rarely, MGUS can be a precursor to cancer, such as multiple myeloma, or other serious blood disorders. But for most people, MGUS is harmless and doesn't cause symptoms or require treatment.
MGUS is a common condition that becomes more prevalent with age. About 3 percent of people 50 and older and 5 percent of those 70 and older have M protein in their blood. The highest incidence is among adults age 85 and older. And MGUS is more common in men than in women.
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 28 Sep 2009 • 1 answer
Posted 2 Jul 2010 • 1 answer
Posted 15 Nov 2012 • 2 answers
Posted 15 Oct 2013 • 1 answer
Posted 22 Feb 2017 • 0 answers